Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
- 1 March 2004
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1697 (1-2) , 89-101
- https://doi.org/10.1016/j.bbapap.2003.11.016
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Disruption of the c-JUN-JNK Complex by a Cell-permeable Peptide Containing the c-JUN δ Domain Induces Apoptosis and Affects a Distinct Set of Interleukin-1-induced Inflammatory GenesJournal of Biological Chemistry, 2003
- JNK phosphorylates paxillin and regulates cell migrationNature, 2003
- Disruption of Basal JNK Activity Differentially Affects Key Fibroblast Functions Important for Wound HealingJournal of Biological Chemistry, 2003
- JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissureGenes & Development, 2003
- Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathwayThe EMBO Journal, 2002
- The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumorsJournal of Human Genetics, 2001
- CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase FamilyPublished by Elsevier ,2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Genomic Organization, Fine-Mapping, and Expression of the HumanIslet-Brain 1 (IB1)/C-Jun-Amino-Terminal Kinase Interacting Protein-1 (JIP-1)GeneGenomics, 1999
- The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye.Genes & Development, 1996